SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-21-015330
Filing Date
2021-08-03
Accepted
2021-08-03 16:11:00
Documents
79
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q xfor-20210630.htm   iXBRL 10-Q 1587937
2 EX-31.1 ex-311q22021.htm EX-31.1 9370
3 EX-31.2 ex-312q22021.htm EX-31.2 9351
4 EX-32.1 ex-321q22021.htm EX-32.1 7074
10 xfor-20210630_g1.jpg GRAPHIC 45340
  Complete submission text file 0001628280-21-015330.txt   6736430

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xfor-20210630.xsd EX-101.SCH 52483
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT xfor-20210630_cal.xml EX-101.CAL 61836
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT xfor-20210630_def.xml EX-101.DEF 180105
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xfor-20210630_lab.xml EX-101.LAB 568313
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xfor-20210630_pre.xml EX-101.PRE 364444
11 EXTRACTED XBRL INSTANCE DOCUMENT xfor-20210630_htm.xml XML 1039320
Mailing Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134
Business Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134 857-529-8300
X4 Pharmaceuticals, Inc (Filer) CIK: 0001501697 (see all company filings)

IRS No.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38295 | Film No.: 211139840
SIC: 2836 Biological Products, (No Diagnostic Substances)